Raju K. Pillai, M.D.
Location
Duarte Cancer Center
Duarte, CA 91010
Education & Experience
2009, Diplomate, American Board of Pathology, Anatomic and Clinical Pathology
2008, Licensure, Medical Board of California
2010, Licensure, State Board of Medicine, Pennsylvania
2011, Diplomate, American Board of Pathology, Molecular Genetic Pathology
2012, Diplomate, American Board of Pathology, Hematopathology
1986-1992, Medical School (MBBS), Calicut Medical College, Kozhikode, India
2010-2011, Fellow in Hematopathology, University of Pittsburgh Medical Center, Pittsburgh
2009-2010, Fellow in Molecular Genetic Pathology, University of Pittsburgh Medical Center, Pittsburgh
1999-2005, Post-doctoral fellow in Transplantation Immunology, Cedars-Sinai Medical Center, Los Angeles.
2005-2009, Resident in Anatomic and Clinical Pathology, University of Southern California, Los Angeles
1994-1997, Resident in Clinical Pathology, All India Institute of Medical Sciences, New Delhi, India
1992-1993, Intern, Calicut Medical College, Kozhikode, India.
2023-present, Associate Clinical Professor, Hematopathologist and Molecular Pathologist, Department of Pathology, City of Hope, Duarte, CA
2015-2023, Assistant Clinical Professor, Hematopathologist and Molecular Pathologist, Department of Pathology, City of Hope, Duarte, CA
2012-2014, Hematopathologist/Molecular Pathologist Medical Director, Pathology Bioinformatics Cedars-Sinai Medical Center, Los Angeles, CA
2011-2012, Clinical Instructor in Hematopathology, University of Pittsburgh Medical Center, Pittsburgh, PA
Research
Lab Members
- Anand V, Dinda AK, Raju KR, Arora M, Tiwari SC, Srivastava LM. Differential CR1 expression in adult and pediatric age groups of patients with minimal change nephrotic syndrome. Nephron 1997; 77:482-3 [PMID: 9434074].
- Luthra K, Vashisht S, Chhabra S, Raju KR, Aggarwal DP, Manchanda SC and Srivastava LM. Lp(a) phenotypes and levels in angiographically proven coronary heart disease patients and controls. Indian Journal of Clinical Biochemistry 1998; 13:12-19.
- Sivasankar B, Anand V, Raju KR, Dinda AK, Tiwari SC, Bagga A, Srivastava RN and Srivastava LM. A tissue specific impairment of complement receptor 1 (CD35) in nephrotic syndrome pediatric kidneys. Indian Journal of Nephrology 1998; 2:155-160
- Sivasankar B, Raju KR, Anand V, Malu S, Padmanabhan S, Tiwari SC, Das N and LM Srivastava. Levels of plasma soluble complement receptor 1(sCR1) in normal Indian adult population. Indian Journal of Clinical Biochemistry 1999; 14: 237-240
- Sivasankar B, Raju KR, Ayub S, Srivastava LM, Das N. Validation of an ELISA for the quantitation of human complement receptor 1. J Immunoassay Immunochem 2001; 22: 289-97 [PMID: 11506278]
- Raju KR, Sivasankar B, Anand V, Luthra K, Tiwari SC, Dinda AK, Das N, Srivastava LM. Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies. Asian Pac J Allergy Immunol 2001; 19:23-7 [PMID: 11495296].
- Radha R, Jordan S, Puliyanda D, Bunnapradist S, Petrosyan A, Amet N, Toyoda M. Cellular immune responses to cytomegalovirus in renal transplant recipients. American Journal of Transplantation 2005; 5:110-7 [PMID: 15636618].
- Toyoda M, Puliyanda DP, Amet N, Baden L, Cam V, Radha R, Pao A, Vo A, Bunnapradist S, Moudgil A, Jordan SC. Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. Transplantation. 2005; 80:198-205. [PMID: 16041264]
- Puliyanda DP, Silverman NS, Lehman D, Vo A, Bunnapradist S, Radha R, Toyoda M, Jordan SC. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis. 2005; 7:71-4. [PMID: 16150094]
- Puliyanda DP, Amet N, Dhawan A, Hilo L, Radha R, Bunnapradist S, Czer L, Martin P, Jordan S, Toyoda M. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy. Clin Transplant. 2006; 20:289-94. [PMID: 16824143]
- Toyoda M, Pao A, Vo A, Lukovsky M, Radha R, Sado T, Ge S, Reinsmoen N, Chai NN, Baden L, Petrosyan A, Skinner E, Mirocha J, Jordan SC. Intracellular IFN gamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Transpl Immunol. 2010 Feb;22(3-4):121-7. [PMID: 19944759].
- Sharma KG, Radha R, Pao A, Amet N, Baden L, Jordan SC, Toyoda M. Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction. Transpl Immunol. 2010 Jul;23(3):117-20 [PMID: 20450974]
- Oleg E. Akilov, Raju K. Pillai, Lisa M. Grandinetti, Jeffrey A. Kant, Larisa Geskin. Clonal T-cell receptor ?-chain gene rearrangements in differential diagnostics of lymphomatoid papulosis from skin metastasis of nodal anaplastic large cell lymphoma. Arch Dermatol. 2011; 147:943-947
- Marian Rollins-Raval, Raju Pillai, Katsuhiko Warita, Tomoko Mitsuhashi-Warita, R Mehta, Michael Boyiadzis, Miroslav Djokic, Jeffrey Kant, Christine Roth. "CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 Mutations." Appl Immunohistochem Mol Morphol. 2012 Aug 20. [Epub ahead of print]
- Raju K. Pillai, Malini Sathanoori, S. Branden VanOss, Steven H. Swedlow (2012). Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas." American Journal of Surgical Pathology. 2013 Mar;37(3):323-32.
- Pillai RK, Surti U, Swerdlow SH. Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies. Haematologica. 2013 Oct;98(10):1571-80.
Awards & Memberships
Memberships
2007, United States and Canadian Academy of Pathology
2007, College of American Pathology
2009, Association for Molecular Pathology
2011, Society for Hematopathology